Anti-Human CD115 Recombinant Antibody(Cabiralizumab)
- 
									
产品编号
YR1397
 - 
									
别名
科研级 Cabiralizumab ( 卡比利珠单抗 ), Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab
 - 
									
规格
- 1mg
 - 5mg
 
 
| Catalog Number | YR1397 | 
| Alias | 科研级 Cabiralizumab ( 卡比利珠单抗 ), Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab | 
| Size | 1mg, 5mg | 
| Molecular Name | Cabiralizumab | 
| CAS Number | 1613144-80-1 | 
| Target | CD115[Homo sapiens] | 
| Antibody Isotype | IgG4 Kappa | 
| Clonity | Monoclonal | 
| Concentration | 1mg/ml | 
| Purity | >95% as determined by SDS-PAGE | 
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | Shipped on ice packs. | 
| Background | CSF1R inhibitionitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment. As of 2017, CSF1R inhibitionitors that are currently in early stage clinical trials include Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4, MCS110, and Cabiralizumab. | 
| Application | ELISA, IHC, IF, IP, FCM, Inhib | 
| Remarks | This product is for research use only. | 
							
							
							
							
						
								0